Michael D. Stutz

2.0k total citations
15 papers, 850 citations indexed

About

Michael D. Stutz is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Michael D. Stutz has authored 15 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in Michael D. Stutz's work include Cell death mechanisms and regulation (4 papers), Tuberculosis Research and Epidemiology (4 papers) and Immunotherapy and Immune Responses (3 papers). Michael D. Stutz is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Tuberculosis Research and Epidemiology (4 papers) and Immunotherapy and Immune Responses (3 papers). Michael D. Stutz collaborates with scholars based in Australia, United States and Canada. Michael D. Stutz's co-authors include Hilda A. Pickett, Marc Pellegrini, Roger R. Reddel, Dimitri Conomos, Mark Hills, Samar Ojaimi, Cody C. Allison, Simon Preston, Tracy M. Bryan and John Silke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Cell Biology.

In The Last Decade

Michael D. Stutz

15 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael D. Stutz Australia 12 576 198 181 132 128 15 850
Regina Voglauer Austria 17 562 1.0× 188 0.9× 205 1.1× 316 2.4× 166 1.3× 23 1.1k
Yongxin Mu China 19 480 0.8× 235 1.2× 37 0.2× 185 1.4× 68 0.5× 33 905
Kara Carter United States 10 222 0.4× 237 1.2× 67 0.4× 189 1.4× 88 0.7× 17 670
Xiaojing Chi China 11 232 0.4× 112 0.6× 56 0.3× 122 0.9× 163 1.3× 31 584
Xavier Legras United States 11 404 0.7× 129 0.7× 27 0.1× 317 2.4× 56 0.4× 14 726
Krishna Kumar India 13 407 0.7× 142 0.7× 22 0.1× 437 3.3× 71 0.6× 28 946
Zhijun Su China 17 310 0.5× 267 1.3× 18 0.1× 280 2.1× 101 0.8× 47 822
Allon Canaan United States 14 383 0.7× 150 0.8× 48 0.3× 202 1.5× 28 0.2× 23 698
Baharak Khadang Italy 10 210 0.4× 115 0.6× 32 0.2× 83 0.6× 51 0.4× 13 474
Yusuke Murakami Japan 17 276 0.5× 158 0.8× 60 0.3× 495 3.8× 55 0.4× 43 799

Countries citing papers authored by Michael D. Stutz

Since Specialization
Citations

This map shows the geographic impact of Michael D. Stutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Stutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Stutz more than expected).

Fields of papers citing papers by Michael D. Stutz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Stutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Stutz. The network helps show where Michael D. Stutz may publish in the future.

Co-authorship network of co-authors of Michael D. Stutz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Stutz. A scholar is included among the top collaborators of Michael D. Stutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Stutz. Michael D. Stutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bird, Catherina H., Cody C. Allison, Daniel Enosi Tuipulotu, et al.. (2022). Mpeg1 is not essential for antibacterial or antiviral immunity, but is implicated in antigen presentation. Immunology and Cell Biology. 100(7). 529–546. 5 indexed citations
2.
Teh, Charis E., Simon Preston, Alissa K. Robbins, et al.. (2022). Caspase-8 has dual roles in regulatory T cell homeostasis balancing immunity to infection and collateral inflammatory damage. Science Immunology. 7(69). eabn8041–eabn8041. 15 indexed citations
3.
Clark, Michelle P., Shringar Rao, Liana Mackiewicz, et al.. (2021). Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models. Cell Death and Disease. 12(7). 641–641. 8 indexed citations
4.
Stutz, Michael D., Cody C. Allison, Samar Ojaimi, et al.. (2021). Macrophage and neutrophil death programs differentially confer resistance to tuberculosis. Immunity. 54(8). 1758–1771.e7. 66 indexed citations
5.
Stutz, Michael D., Samar Ojaimi, Gregor Ebert, & Marc Pellegrini. (2018). Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for Mycobacterium tuberculosis Infection?. Frontiers in Immunology. 9. 1178–1178. 12 indexed citations
6.
Seillet, Cyril, Derek Lacey, Michael D. Stutz, et al.. (2018). Constitutive overexpression of TNF in BPSM1 mice causes iBALT and bone marrow nodular lymphocytic hyperplasia. Immunology and Cell Biology. 97(1). 29–38. 1 indexed citations
7.
Stutz, Michael D., Samar Ojaimi, Cody C. Allison, et al.. (2017). Necroptotic signaling is primed in Mycobacterium tuberculosis-infected macrophages, but its pathophysiological consequence in disease is restricted. Cell Death and Differentiation. 25(5). 951–965. 70 indexed citations
8.
Stutz, Michael D., Michelle P. Clark, Marcel Doerflinger, & Marc Pellegrini. (2017). Mycobacterium tuberculosis: Rewiring host cell signaling to promote infection. Journal of Leukocyte Biology. 103(2). 259–268. 48 indexed citations
9.
Stutz, Michael D., Alexander P. Sobinoff, Christopher G. Tomlinson, et al.. (2015). A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase. PLoS Genetics. 11(6). e1005286–e1005286. 35 indexed citations
10.
Ebert, Gregor, Simon Preston, Cody C. Allison, et al.. (2015). Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus. Proceedings of the National Academy of Sciences. 112(18). 5797–5802. 75 indexed citations
11.
Stutz, Michael D., Aline Mamo, David Valenti, et al.. (2015). Real-Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer. Gastroenterology Research and Practice. 2015. 1–6. 15 indexed citations
12.
Ebert, Gregor, Cody C. Allison, Simon Preston, et al.. (2015). Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis. Proceedings of the National Academy of Sciences. 112(18). 5803–5808. 93 indexed citations
13.
Kojima, Yoji, Keren Kaufman‐Francis, Joshua B. Studdert, et al.. (2013). The Transcriptional and Functional Properties of Mouse Epiblast Stem Cells Resemble the Anterior Primitive Streak. Cell stem cell. 14(1). 107–120. 221 indexed citations
14.
Lee, Michael, Mark Hills, Dimitri Conomos, et al.. (2013). Telomere extension by telomerase and ALT generates variant repeats by mechanistically distinct processes. Nucleic Acids Research. 42(3). 1733–1746. 75 indexed citations
15.
Conomos, Dimitri, Michael D. Stutz, Mark Hills, et al.. (2012). Variant repeats are interspersed throughout the telomeres and recruit nuclear receptors in ALT cells. The Journal of Cell Biology. 199(6). 893–906. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Regina Voglauer Breakdown of academic impact, for papers by Yongxin Mu Breakdown of academic impact, for papers by Kara Carter Breakdown of academic impact, for papers by Xiaojing Chi Breakdown of academic impact, for papers by Xavier Legras Breakdown of academic impact, for papers by Krishna Kumar Breakdown of academic impact, for papers by Zhijun Su Breakdown of academic impact, for papers by Allon Canaan Breakdown of academic impact, for papers by Baharak Khadang Breakdown of academic impact, for papers by Yusuke Murakami
Rankless by CCL
2026